F-star Therapeutics, Inc.
FSTXDelisted Mar 9, 2023- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001566373
F-star Therapeutics, Inc. was delisted on Mar 9, 2023; its insiders filed their last Form 4 on Mar 9, 2023; 59 institutions reported holding it in 13F filings for Q4 2022, worth $57.8M in total; Fairfax Financial was the only superinvestor holding it.
Q3 2022 vs. Q2 2022
How the institutions holding F-star Therapeutics, Inc. changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 53 | 1 | 54 | +2 |
| Shares | 7.19M | 4.69K | 6.92M | −264.1K (−3.7%) |
| Value | $45.1M | $29.0K | $35.5M | −$9.54M (−21.2%) |
1 institution that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (13)
Institutions that held F-star Therapeutics, Inc. at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AlphaCentric Advisors LLC | 165,000 | $845.0K | 0.87% |
| Murchinson Ltd. | 162,624 | $833.0K | 0.24% |
| Jane Street Group, LLC | 136,130 | $697.0K | 0.00% |
| HRT Financial LP | 109,120 | $558.0K | 0.01% |
| Boothbay Fund Management, LLC | 81,313 | $416.0K | 0.01% |
| S. Muoio & Co. LLC | 40,000 | $205.0K | 0.27% |
| Tower Research Capital LLC (TRC) | 32,298 | $165.0K | 0.00% |
| Hunting Hill Global Capital, LLC | 26,798 | $137.0K | 0.08% |
| Fairfax Financial Holdings LtdSuperinvestorFairfax Financial | 24,399 | $125.0K | 0.00% |
| Squarepoint Ops LLC | 18,693 | $96.0K | 0.00% |
| Balyasny Asset Management LLC | 14,483 | $74.0K | 0.00% |
| Millennium Management LLC | 12,099 | $62.0K | 0.00% |
| Royal Bank of Canada | 186 | $1.00K | 0.00% |
Sold out (11)
Institutions that held F-star Therapeutics, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Point72 Asset Management, L.P. | 91,761 | $574.0K |
| Manufacturers Life Insurance Company, The | 54,981 | $348.0K |
| TD Asset Management Inc | 39,687 | $248.0K |
| Parsons Capital Management Inc | 36,291 | $227.0K |
| Wolverine Trading, LLC | 16,351 | $104.0K |
| Jump Financial, LLC | 16,500 | $103.0K |
| Charles Schwab Investment Management Inc | 12,327 | $78.0K |
| UBS Group AG | 2,224 | $14.0K |
| Total Clarity Wealth Management, Inc. | 2,000 | $13.0K |
| JPMorgan Chase & Co | 1,498 | $9.00K |
| TCI Wealth Advisors, Inc. | 300 | $2.00K |
Not filed for Q3 2022 yet (1)
Institutions that held F-star Therapeutics, Inc. at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Urban Wealth Management, LLC | 4,691 | $29.0K |